Scoping review highlights gaps in health equity and digital access in clinical validation of digital therapeutics.
Clinical validation studies of DTx lack sufficient assessment of health equity, cultural competence, and digital accessibility. Addressing these gaps is essential to ensure equitable access and effectiveness for diverse populations.
No takes yet. Share an insight, caveat, or question.
Divatia et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: